People · Operator
Named in public records as an officer, director or promoter · active 2011–2022 · Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Ribon Therapeutics, Inc. | — | Biotechnology | Series B | $119.1M | $342.8M | 2022 |
| Agile Nanotech Inc | — | Other Technology | Pre-Seed | $273K | $11.5M | 2011 |
Gary Sutton at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Gary Sutton on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jonathan Root | 1 | 16 |
| Cameron Wheeler | 1 | 9 |
| Jeff Goater | 1 | 4 |
| Emma Reeve | 1 | 4 |
| Paul Brannelly | 1 | 4 |
| LAURA BRASS | 1 | 3 |
| Eyal Lifschitz | 1 | 3 |
| William M. Harrington | 1 | 2 |
| Laurence Lasky | 1 | 2 |
| Cameron M. Wheeler | 1 | 1 |
| James M. Audia | 1 | 1 |
| Emma M. Reeve | 1 | 1 |
| Jodie M. Morrison | 1 | 1 |
| Laura M. Brass | 1 | 1 |
| Anja M. Koenig | 1 | 1 |
| David M. Cordo | 1 | 1 |
| GREG SHELTON | 1 | 1 |
| FRANK CREEDE | 1 | 1 |
| YU QIAO | 1 | 1 |
| DOUGLAS GIESE | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.